Back to Newsroom

Cyclacel Reviews 2017 Achievements and Announces Key Business Objectives for 2018

BERKELEY HEIGHTS, N.J., Jan. 09, 2018 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company) reviewed its 2017 achievements and provided an outline of the Company’s key business objectives for 2018.  These will be highlighted at the Company’s presentation during the Biotech Showcase™ 2018 Conference at 2:30 p.m. PST, Tuesday, January 9, 2018, at the Hilton San Francisco Union Square in San Francisco.